Abstract:Objective: As an aberrant response to cutaneous wound healing, keloid scarring is a challenge to cure, and its clinical management remains unsatisfactory. The purpose of this study was to investigate whether mitochondrial function and morphology were impaired in keloid pathology. Approach: Keloid fibroblasts (KFs) and normal skin fibroblasts (NFs) were isolated and cultured from excised samples. A real-time extracellular flux analyzer was used to monitor the oxygen consumption rate for evaluating the mitochondrial respiratory function. Real-time PCR or Western blot was performed to detect the levels of mRNAs or proteins, respectively, including those associated with the tricarboxylic acid cycle, mitochondrial fission and fusion, and mitochondrial biogenesis. The reactive oxygen species (ROS) level and the mitochondrial mass were measured by flow cytometry. Mitochondrial ultrastructure was observed by transmission electron microscopy. Results: Compared with NFs, KFs showed reduced basal oxidative respiration (p < 0.05), maximal oxidative respiratory capacity, ATP production, and coupling efficiency (p < 0.01) but increased proton leakage (p < 0.01). ROS were decreased (p < 0.05) in KFs, whereas the mitochondrial mass was increased (p < 0.01). The mRNA and protein expressions related to mitochondrial dynamics (fission and fusion) and biogenesis were significantly upregulated in KFs (p < 0.05). Mitochondria in both KFs and keloid tissue were distended and swollen, along with displaying vacuolization and effacement of the cristae. Innovation: The possible involvement of mitochondrial abnormities in keloid pathology may promote promising therapeutic strategies for wound healing disorders. Conclusion: Collectively, our data suggested that both mitochondrial dysfunction and morphological impairment might play vital roles during keloid pathogenesis.

Targeting Nuclear Mechanics Mitigates the Fibroblast Invasiveness in Pathological Dermal Scars Induced by Matrix Stiffening (Adv. Sci. 15/2024)

Mapping the 3D Remodeling of the Extracellular Matrix in Human Hypertrophic Scar by Multi-Parametric Multiphoton Imaging Using Endogenous Contrast

Comprehensive Modular Analyses of Scar Subtypes Illuminate Underlying Molecular Mechanisms and Potential Therapeutic Targets.

Improved Dermal Regeneration Using a Combination of Dermal Substitutes and Dermal Fibroblast Optimization: A Hypothesis.

Fibroblasts and endothelial cells interplay drives hypertrophic scar formation: Insights from in vitro and in vivo models

Down-Regulating Scar Formation by Microneedles Directly via a Mechanical Communication Pathway

Genetic trends in hunting behaviour in the Finnish Hound

Biological Effects of Cellular Stretch on Human Dermal Fibroblasts.

Reaction of human smooth muscle autoantibody with foetal glial cells and their precursors.

Advances of Nanobiomaterials for Treating Skin Pathological Fibrosis

Keloid fibroblasts have elevated and dysfunctional mechanotransduction signaling that is independent of TGF-β

Endothelial Dysfunction and Mechanobiology in Pathological Cutaneous Scarring: Lessons Learned from Soft Tissue Fibrosis

Mitochondrial Dysfunction and Morphological Abnormality in Keloid Fibroblasts

[Role of potassium ions in the activity of Pacinian corpuscles].

Increased Susceptibility to Mechanical Stretch Drives the Persistence of Keloid Fibroblasts: An Investigation Using a Stretchable PDMS Platform

Keloid Progression: A Stiffness Gap Hypothesis

Injury triggers fascia fibroblast collective cell migration to drive scar formation through N-cadherin

Relationship of the Length of the First Stage of Labor to the Length of the Second Stage

Endogenous stimuli-responsive separating microneedles to inhibit hypertrophic scar through remodeling the pathological microenvironment

Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation

Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.